Anti-CD3抗体[B355.1 (RIV-9)] (ab8671)

发表研究结果有使用 ab8671?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab8671 被引用在 5 文献中.

  • Halum SL  et al. Stem cell-derived tissue-engineered constructs for hemilaryngeal reconstruction. Ann Otol Rhinol Laryngol 123:124-34 (2014). Rat . PubMed: 24574468
  • Johnson G  et al. In vitro assessment of blood compatibility: residual and dynamic markers of cellular activation. J Biomater Appl 27:925-36 (2013). Human . PubMed: 22210807
  • Jiskoot W  et al. Purification and stabilisation of a poorly soluble mouse IgG3 monoclonal antibody. J Immunol Methods 138:181-9 (1991). PubMed: 1827821
  • Vaessen LM  et al. RIV-9: a mouse IgG3 anti-human CD3 monoclonal antibody with strong antigen modulating and T cell eliminating properties. Transplant Proc 21:1026-7 (1989). PubMed: 2523112
  • Ceuppens JL & Van Vaeck F Human T cell activation induced by a monoclonal mouse IgG3 anti-CD3 antibody (RIV9) requires binding of the Fc part of the antibody to the monocytic 72-kDa high-affinity Fc receptor (FcRI). Cell Immunol 118:136-46 (1989). PubMed: 2521302

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"